CompletedNot Applicable

Postmarket Study of Tarvos Microguidewire in Neurovascular Interventional Surgery

China121 participantsStarted 2026-01-29

Plain-language summary

This investigation is to evaluate the clinical effectiveness and safety of the Tarvos Microguidewire in the neurovascular interventional surgery. It is a retrospective multicenter medical device clinical study with real-world data.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Undertaken a neurovascular surgery procedure including Tarvos microguidewire * Available images of Tarvos Microguidewire in the neurovascular surgery. Exclusion Criteria: * Disorders of vascular fragility (e.g. Ehlers-Danlos syndrome) * Prior vascular dissection or injury to the target vessels * Not meeting the data requirements needed for this study.

What they're measuring

Device success rate

Timeframe: during surgery

Trial details

NCT IDNCT07500155

SponsorKeuro MedTech

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-03-15

View on ClinicalTrials.gov More Intracranial Aneurysm trials